Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
V. Simon Mittal, Bingcao Wu, Ji Song, Dejan Milentijevic, Veronica Ashton & Dheeraj Mahajan. (2020) Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study. Current Medical Research and Opinion 36:4, pages 529-536.
Read now
Read now
Articles from other publishers (23)
Henning Ebelt & Markus Götze. (2023) Prävalenz, Inzidenz und prädiktive Faktoren von Vorhofflimmern (VHF) bei geriatrischen Patienten – eine prospektive BeobachtungsstudiePrevalence, incidence and predictive factors of atrial fibrillation in geriatric patients—A prospective observational study. Zeitschrift für Gerontologie und Geriatrie.
Crossref
Crossref
Luigi Vignali, Filippo Luca Gurgoglione, Federico Barocelli, Maria Alberta Cattabiani, Emilia Solinas, Arianna Maini, Iacopo Tadonio, Giorgio Benatti, Giovanna Pelà, Stefano Coli, Diego Ardissino & Giampaolo Niccoli. (2023) Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens. International Journal of Cardiology 371, pages 92-99.
Crossref
Crossref
Roberto Presta, Enrico Brunetti, Maria Cristina Polidori & Mario Bo. (2022) Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review. Ageing Research Reviews 82, pages 101761.
Crossref
Crossref
Andrea Sonaglioni, Chiara Lonati, Elisabetta Rigamonti, Mauro Viganò, Gian Luigi Nicolosi, Marco Proietti, Michele Lombardo & Sergio Harari. (2022) CHA2DS2-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation. Aging Clinical and Experimental Research 34:7, pages 1707-1720.
Crossref
Crossref
Mary Bul, Fahad Shaikh, Julee McDonagh & Caleb Ferguson. (2022) Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review. AGING MEDICINE.
Crossref
Crossref
S. G. Kanorskii. (2022) Atrial fibrillation in old age: current treatment options. South Russian Journal of Therapeutic Practice 3:1, pages 7-14.
Crossref
Crossref
Kori Leblanc, Jenny MacGillivray, Amanda Carroccia, Laurent Macle & Jason G. Andrade. (2021) The 2020 CCS atrial fibrillation guidelines for pharmacists: Top 10 takeaways. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 155:2, pages 107-118.
Crossref
Crossref
Annabelle Santos Volgman, Gatha Nair, Radmila Lyubarova, Faisal M. Merchant, Pamela Mason, Anne B. Curtis, Nanette K. Wenger, Neelum T. Aggarwal, James N. Kirkpatrick & Emelia J. Benjamin. (2022) Management of Atrial Fibrillation in Patients 75 Years and Older. Journal of the American College of Cardiology 79:2, pages 166-179.
Crossref
Crossref
Maximilian Hupfer & Markus Gosch. (2021) Anticoagulation in Very Old Patients with Atrial Fibrillation (AVOPA): A Descriptive Observational Study. Drugs - Real World Outcomes 8:4, pages 603-614.
Crossref
Crossref
Wenfei Wei, Rafia S. Rasu, José J. Hernández-Muñoz, Renee J. Flores, Nahid J. Rianon, Genesis A. Hernández-Vizcarrondo & Adam T. Brown. (2021) Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis. Drugs & Aging 38:8, pages 713-723.
Crossref
Crossref
Kirolos Barssoum, Ashish Kumar, Samarthkumar Thakkar, Aakash R. Sheth, Adnan Kharsa, Mounir Ibrahim, Devesh Rai, Osarenren Idemudia, Navya Akula, Harsh P. Patel, Ahmed Mowafy, Ahmed Elkaryoni, Fadi Ibrahim, Mahmood Mubasher, Kyrillos N. Ghattas & Mohan Rao. (2021) Meta-analysis of Safety and Efficacy of Anticoagulation versus no Anticoagulation in Octogenarians and Nonagenarians with Atrial Fibrillation. High Blood Pressure & Cardiovascular Prevention 28:3, pages 271-282.
Crossref
Crossref
Valeria Calsolaro, Chukwuma Okoye, Rachele Antognoli, Umberto Dell'Agnello, Alessia Maria Calabrese & Fabio Monzani. (2021) Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation. European Journal of Internal Medicine 86, pages 91-97.
Crossref
Crossref
Masayuki Ohta, Kentaro Hayashi, Yuichiro Mori, Hiroyuki Sato, Takahiro Noto, Kandoh Kawahatsu, Tomohiro Mita, Yoshio Kazuno, Shunsuke Sasaki, Takahiro Doi, Mitsugu Hirokami, Shigemichi Tanaka & Satoshi Yuda. (2021) Impact of Frailty on Bleeding Events Related to Anticoagulation Therapy in Patients With Atrial Fibrillation. Circulation Journal 85:3, pages 235-242.
Crossref
Crossref
Hiroshi Hori, Takahiko Fukuchi & Hitoshi Sugawara. (2021) Anticoagulant Therapy for Frail Patients with Atrial Fibrillation. Internal Medicine 60:4, pages 495-506.
Crossref
Crossref
Jason G. Andrade, Martin Aguilar, Clare Atzema, Alan Bell, John A. Cairns, Christopher C. Cheung, Jafna L. Cox, Paul Dorian, David J. Gladstone, Jeff S. Healey, Paul Khairy, Kori Leblanc, M. Sean McMurtry, L. Brent Mitchell, Girish M. Nair, Stanley Nattel, Ratika Parkash, Louise Pilote, Roopinder K. Sandhu, Jean-François Sarrazin, Mukul Sharma, Allan C. Skanes, Mario Talajic, Teresa S.M. Tsang, Atul Verma, Subodh Verma, Richard Whitlock, D. George Wyse & Laurent Macle. (2020) The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology 36:12, pages 1847-1948.
Crossref
Crossref
Yoshihiro Uchikado, Yoshiyuki Ikeda & Mitsuru Ohishi. (2020) Current Understanding of the Role of Frailty in Cardiovascular Disease. Circulation Journal 84:11, pages 1903-1908.
Crossref
Crossref
Leonardo Bencivenga, Klara Komici, Pierangela Nocella, Fabrizio Vincenzo Grieco, Angela Spezzano, Brunella Puzone, Alessandro Cannavo, Antonio Cittadini, Graziamaria Corbi, Nicola Ferrara & Giuseppe Rengo. (2020) Atrial fibrillation in the elderly: a risk factor beyond stroke. Ageing Research Reviews 61, pages 101092.
Crossref
Crossref
Carmen Suárez Fernández, Alejandra Gullón & Francesc Formiga. (2020) The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation. Journal of Comparative Effectiveness Research 9:7, pages 509-523.
Crossref
Crossref
Dheeraj Mahajan, Bingcao Wu, Ji Song, Dejan Milentijevic, Veronica Ashton & V. Simon Mittal. (2020) Comparison of Healthcare Resource Utilization and Costs between Rivaroxaban and Warfarin for Nonvalvular Atrial Fibrillation in a Skilled Nursing Facility Setting. Drugs & Aging 37:4, pages 281-289.
Crossref
Crossref
Z. B. Wojszel & A. Kasiukiewicz. (2019) Determinants of anticoagulant therapy in atrial fibrillation at discharge from a geriatric ward: cross sectional study. Journal of Thrombosis and Thrombolysis 49:1, pages 18-26.
Crossref
Crossref
Zafraan Zathar, Anne Karunatilleke, Ameenathul M. Fawzy & Gregory Y. H. Lip. (2019) Atrial Fibrillation in Older People: Concepts and Controversies. Frontiers in Medicine 6.
Crossref
Crossref
Tiberiu A. Pana, Jesus A. Perdomo-Lampignano & Phyo K. Myint. (2019) Prevention and Treatment of Acute Stroke in the Nonagenarians and Beyond: Medical and Ethical Issues. Current Treatment Options in Neurology 21:6.
Crossref
Crossref
Luigi Vignali, Filippo Luca Luca Gurgoglione, Federico Barocelli, Maria Alberta Cattabiani, Emilia Solinas, Arianna Maini, Iacopo Tadonio, Giorgio Benatti, Giovanna Pelà, Stefano Coli, Diego Ardissino & Giampaolo Niccoli. (2022) Looking for Optimal Antithrombotic Strategy after Transcatheter Left Atrial Appendage Occlusion: A Real-World Comparison of Different Antiplatelet Regimens. SSRN Electronic Journal.
Crossref
Crossref